BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34564169)

  • 1. RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study.
    Mayer AMS; Hall ML; Lach J; Clifford J; Chandrasena K; Canton C; Kontoyianni M; Choo YM; Karan D; Hamann MT
    Mar Drugs; 2021 Sep; 19(9):. PubMed ID: 34564169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.
    Smith JA; Poteet-Smith CE; Malarkey K; Sturgill TW
    J Biol Chem; 1999 Jan; 274(5):2893-8. PubMed ID: 9915826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
    Zhao Y; Bjorbaek C; Moller DE
    J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines.
    Mayer AM; Hall ML; Lynch SM; Gunasekera SP; Sennett SH; Pomponi SA
    BMC Pharmacol; 2005 Mar; 5():6. PubMed ID: 15762999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs.
    Bhatt RR; Ferrell JE
    J Biol Chem; 2000 Oct; 275(42):32983-90. PubMed ID: 10934212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
    Ikuta M; Kornienko M; Byrne N; Reid JC; Mizuarai S; Kotani H; Munshi SK
    Protein Sci; 2007 Dec; 16(12):2626-35. PubMed ID: 17965187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of RSK substrates using an analog-sensitive kinase approach.
    Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
    J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two p90 ribosomal S6 kinase isoforms are involved in the regulation of mitotic and meiotic arrest in Artemia.
    Duan RB; Zhang L; Chen DF; Yang F; Yang JS; Yang WJ
    J Biol Chem; 2014 Jun; 289(23):16006-15. PubMed ID: 24755224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of some functional group compounds substituted 8-Manzamine A as RSK1 inhibitors: molecular docking and molecular dynamics simulations.
    Zayed AOH; Altarabeen M; AlShamaileh E; Zain SM
    J Biomol Struct Dyn; 2024 Feb; ():1-10. PubMed ID: 38319051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK.
    Richards SA; Fu J; Romanelli A; Shimamura A; Blenis J
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):810-20. PubMed ID: 10469565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer.
    Yang WS; Caliva MJ; Khadka VS; Tiirikainen M; Matter ML; Deng Y; Ramos JW
    Front Cell Dev Biol; 2022; 10():1015665. PubMed ID: 36684450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of RSK1 characterizes high-grade gliomas with immune infiltration.
    M Hajj GN; da Silva FF; de Bellis B; Lupinacci FCS; Bellato HM; Cruz JR; Segundo CNC; Faquini IV; Torres LC; Sanematsu PI; Begnami MD; Martins VR; Roffé M
    Mol Oncol; 2020 Jan; 14(1):159-179. PubMed ID: 31701625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RSK factors of activating the Ras/MAPK signaling cascade.
    Carriere A; Ray H; Blenis J; Roux PP
    Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manzamine A Exerts Anticancer Activity against Human Colorectal Cancer Cells.
    Lin LC; Kuo TT; Chang HY; Liu WS; Hsia SM; Huang TC
    Mar Drugs; 2018 Jul; 16(8):. PubMed ID: 30060617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3beta is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity.
    Cavet ME; Lehoux S; Berk BC
    J Biol Chem; 2003 May; 278(20):18376-83. PubMed ID: 12618428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The manzamine alkaloids.
    Kubota T; Kurimoto SI; Kobayashi J
    Alkaloids Chem Biol; 2020; 84():1-124. PubMed ID: 32416951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-infective Potential of Manzamine Alkaloids - A Review.
    Ashok P; Faheem ; Kumar BK; Chander S; Chandra Sekhar KVG; Sankaranarayanan M
    Med Chem; 2022; 18(6):629-654. PubMed ID: 34344295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.